AlphaCor - Addition Technology Inc.

In general, AlphaCor artificial cornea is suitable for those patients who would benefit from a human donor corneal graft but are either at high risk of graft failure or are unable to receive a graft due to an inability to tolerate the post operative medications associated with donor graft procedures in some high-risk cases.

The appropriate selection of patients for AlphaCor is crucial for its success.

In adults, AlphaCor can be used to replace scarred, vascularized, oedemetus or painful corneal tissue when a conventional donor corneal graft is expected to be unsuccessful or unavailable.

AlphaCor performs best in a relatively normal ocular environment. This includes good eyelid health and tear film production and an absence of any inflammation. Ideally the patient has a functioning retina and the intraocular pressure is normal or controlled. Surgery may be easier if there has been a minimum of 12 months since the most recent donor transplant.

There are a number of factors that would preclude a patient from receiving an AlphaCor. These include:

	●		Age under 18 years (the device is not approved for use in children).
	●		Inability to administer medications at home.
	●		Smoking – smoke has the ability to cause discoloration of the device.
	●		HSV – Pending further trials, a history of ocular Herpes Simplex Virus (HSV) infection is currently considered an exclusion factor for AlphaCor surgery.

Surgeons can find out more about the indications for AlphaCor through the instructions for use available in the surgeon section.

AlphaCor